人工智能增强多算法R闪亮应用预测建模和分析:阿尔茨海默病诊断的案例研究
Han Wenzheng1, Edmund F Agyemang1, Sudesh K Srivastav1
1Department of Biostatistics and Data Science, Celia Scott Weatherhead School of Public Health and Tropical Medicine at Tulane University, 1440 Canal St, New Orleans, LA, 70112, United States, 1 5049882475.
JMIR aging
|December 30, 2025
概括
人工智能 (AI) 在阿尔茨海默病 (AD) 预测方面表现有前途. 使用手写分析,SMART-Pred工具实现了91%的准确性,提供了一种非侵入性的早期检测方法.
科学领域:
- 神经学和人工智能 人工智能
- 生物医学信息学 生物医学信息学
- 计算神经科学是一种神经科学.
背景情况:
- 人工智能 (AI) 在医疗保健中表现出卓越的诊断准确性,在医疗实践中越来越重要.
- SMART-Pred是一种基于人工智能的创新应用程序,旨在通过手写分析来预测阿尔茨海默病 (AD).
研究的目的:
- 开发和评估一种非侵入性,具有成本效益的AI工具,用于早期发现阿尔茨海默病 (AD).
- 解决对AD的可访问和准确查方法的需求.
主要方法:
- 使用主要组件分析来减少手写数据的维度.
- 在达尔文数据集 (174名参与者) 上训练和评估了10个不同的AI模型,包括神经网络.
- 使用准确度,灵敏度,特异性和AUC指标评估模型性能,包括可解释的AI (沙普利增量解释).
主要成果:
- 神经网络分类器在测试组中实现了91%的准确性和94%的AUC,超过了当前的临床诊断工具.
- 在所有模型中",空中时间"和"纸上时间"始终是AD的关键预测因素.
- 人工智能工具的性能与人工智能辅助AD预测的最新进展保持一致.
结论:
- SMART-Pred提供了一种非侵入性,具有成本效益和高效的AD预测方法,展示了AI在医疗保健中的潜力.
- 需要进一步的临床验证,但这些发现支持人工智能辅助的AD诊断,通过早期检测改善患者的治疗结果.
关键词:
在这里,我们可以看到AIAIAI.阿尔茨海默氏症是阿尔茨海默氏症的疾病在 SMART-Pred 中使用.闪亮的多算法R工具用于预测建模.人工智能的人工智能是人工智能.分类算法的分类算法.疾病的诊断和监测.机器学习是机器学习.预测建模预测建模更多相关视频
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.9K
06:46Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
Published on: August 4, 2018
12.7K
相关概念视频
Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
